Kesara Na-Bangchang

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 42

Top Topics

Plasmodium Falciparum

Systematic Review

Gold Nanoparticles

Top Venues

Asian Pacific journal of cancer prevention : APJCP

Integrative cancer therapies

Science progress

This page only lists publications with an associated author ORCID identifier.

Publications

Teerachat Saeheng, Juntra Karbwang, Anurak Cheomung, Nisit Tongsiri, Tullayakorn Plengsuriyakarn, Kesara Na-Bangchang
Pharmacokinetic Analysis of Prognostic Factors in Patients With Advanced-Stage Intrahepatic Cholangiocarcinoma Following the Administration of Capsule Formulation of the Standardized Extract of Atractylodes lancea (Thunb) DC. Integrative cancer therapies 23 (2024)
Teerachat Saeheng, Juntra Karbwang, Anurak Cheomung, Nisit Tongsiri, Tullayakorn Plengsuriyakarn, Kesara Na-Bangchang
Pharmacokinetic Analysis of Prognostic Factors in Patients With Advanced-Stage Intrahepatic Cholangiocarcinoma Following the Administration of Capsule Formulation of the Standardized Extract of Atractylodes lancea (Thunb) DC. Integrative cancer therapies 23 (2024)
Teerachat Saeheng, Juntra Karbwang, Anurak Cheomung, Nisit Tongsiri, Tullayakorn Plengsuriyakarn, Kesara Na-Bangchang
Pharmacokinetic Analysis of Prognostic Factors in Patients With Advanced-Stage Intrahepatic Cholangiocarcinoma Following the Administration of Capsule Formulation of the Standardized Extract of Atractylodes lancea (Thunb) DC. Integrative cancer therapies 23 (2024)
Teerachat Saeheng, Juntra Karbwang, Anurak Cheomung, Nisit Tongsiri, Tullayakorn Plengsuriyakarn, Kesara Na-Bangchang
Pharmacokinetic Analysis of Prognostic Factors in Patients With Advanced-Stage Intrahepatic Cholangiocarcinoma Following the Administration of Capsule Formulation of the Standardized Extract of Atractylodes lancea (Thunb) DC. Integrative cancer therapies 23 (2024)
Nadda Muhamad, Kesara Na-Bangchang
The roles of CYP2C19 and CYP3A4 in the in vitro metabolism of β-eudesmol in human liver: Reaction phenotyping and enzyme kinetics. Pharmacology research & perspectives 11 (6) (2023)
Kesara Na-Bangchang, Monthaka Teerachaisakul, Phunuch Muhamad, Yositha Kasemnitichok, Nattida Sangnarong, Kanyarat Boonprasert, Mayuri Tarasuk, Tullayakorn Plengsuriyakarn
Antiproliferative and Anti-Inflammatory Activities of Deprungsith Formulation and Its Bioactive Compounds Against Mild Psoriasis and Potential of Metabolic Herb-Drug Interactions. Journal of evidence-based integrative medicine 28 (2023)
Rehab Idris, Wanna Chaijaroenkul, Kesara Na-Bangchang
Molecular Targets and Signaling Pathways in Cholangiocarcinoma: A Systematic Review. Asian Pacific journal of cancer prevention : APJCP 24 (3) (2023)
Peeranate Vanaroj, Wanna Chaijaroenkul, Kesara Na-Bangchang
Atractylodin and β-eudesmol from Atractylodes lancea (Thunb.) DC. Inhibit Cholangiocarcinoma Cell Proliferation by Downregulating the Notch Signaling Pathway. Asian Pacific journal of cancer prevention : APJCP 24 (2) (2023)
Kanyarat Boonprasert, Thipaporn Tharavanij, Chiravoot Pechyen, Khanittha Ponsanti, Benchamaporn Tangnorawich, Vithoon Viyanant, Kesara Na-Bangchang
Validation of an electrochemical sensor based on gold nanoparticles as a point-of-care test for quantitative determination of glycated hemoglobin. PloS one 18 (6) (2023)
Teerachat Saeheng, Kesara Na-Bangchang
Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria. PloS one 18 (2) (2023)
Kanyarat Boonprasert, Thipaporn Tharavanij, Chiravoot Pechyen, Khanittha Ponsanti, Benchamaporn Tangnorawich, Vithoon Viyanant, Kesara Na-Bangchang
Validation of an electrochemical sensor based on gold nanoparticles as a point-of-care test for quantitative determination of glycated hemoglobin. PloS one 18 (6) (2023)
Kanyarat Boonprasert, Thipaporn Tharavanij, Chiravoot Pechyen, Khanittha Ponsanti, Benchamaporn Tangnorawich, Vithoon Viyanant, Kesara Na-Bangchang
Validation of an electrochemical sensor based on gold nanoparticles as a point-of-care test for quantitative determination of glycated hemoglobin. PloS one 18 (6) (2023)
Peeranate Vanaroj, Wanna Chaijaroenkul, Kesara Na-Bangchang
Atractylodin and β-eudesmol from Atractylodes lancea (Thunb.) DC. Inhibit Cholangiocarcinoma Cell Proliferation by Downregulating the Notch Signaling Pathway. Asian Pacific journal of cancer prevention : APJCP 24 (2) (2023)
Teerachat Saeheng, Kesara Na-Bangchang
Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria. PloS one 18 (2) (2023)
Teerachat Saeheng, Kesara Na-Bangchang
Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria. PloS one 18 (2) (2023)
Teerachat Saeheng, Kesara Na-Bangchang
Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria. PloS one 18 (2) (2023)
Panida Kongjam, Noel Pabalan, Phuntila Tharabenjasin, Hamdi Jarjanazi, Wanna Chaijaroenkul, Kesara Na-Bangchang
Tumor necrosis factor-α (TNF-α) -308G >a promoter polymorphism (rs1800629) promotes Asians in susceptibility to Plasmodium falciparum severe malaria: A meta-analysis. PLoS neglected tropical diseases 17 (11) (2023)
Rehab Idris, Wanna Chaijaroenkul, Kesara Na-Bangchang
Molecular Targets and Signaling Pathways in Cholangiocarcinoma: A Systematic Review. Asian Pacific journal of cancer prevention : APJCP 24 (3) (2023)
Peeranate Vanaroj, Wanna Chaijaroenkul, Kesara Na-Bangchang
Atractylodin and β-eudesmol from Atractylodes lancea (Thunb.) DC. Inhibit Cholangiocarcinoma Cell Proliferation by Downregulating the Notch Signaling Pathway. Asian Pacific journal of cancer prevention : APJCP 24 (2) (2023)
Bishwanath Acharya, Wanna Chajaroenkul, Kesara Na-Bangchang
β-Eudesmol Inhibits the Migration of Cholangiocarcinoma Cells by Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT and p38MAPK Modulation. Asian Pacific journal of cancer prevention : APJCP 23 (8) (2022)
Nadda Muhamad, Tullayakorn Plengsuriyakarn, Kesara Na-Bangchang
Atractylodes lancea for cholangiocarcinoma: Modulatory effects on CYP1A2 and CYP3A1 and pharmacokinetics in rats and biodistribution in mice. PloS one 17 (11) (2022)
Teerachat Saeheng, Kesara Na-Bangchang
Clinical pharmacokinetics of quinine and its relationship with treatment outcomes in children, pregnant women, and elderly patients, with uncomplicated and complicated malaria: a systematic review. Malaria journal 21 (1) (2022)
Bishwanath Acharya, Wanna Chaijaroenkul, Kesara Na-Bangchang
Atractylodin inhibited the migration and induced autophagy in cholangiocarcinoma cells via PI3K/AKT/mTOR and p38MAPK signalling pathways. The Journal of pharmacy and pharmacology 73 (9) (2022)
Paradon Sonsomnuek, Mayuri Tarasuk, Tullayakorn Plengsuriyakarn, Kanyarat Boonprasert, Kesara Na-Bangchang
Apoptotic and Anti-metastatic Effects of Atractylodes lancea (Thunb.) DC. in a Hamster Model of Cholangiocarcinoma. Asian Pacific journal of cancer prevention : APJCP 23 (9) (2022)
Gyem Tshering, Wittaya Pimtong, Tullayakorn Plengsuriyakarn, Kesara Na-Bangchang
Effects of β-eudesmol and atractylodin on target genes and hormone related to cardiotoxicity, hepatotoxicity, and endocrine disruption in developing zebrafish embryos. Science progress 105 (4) (2022)
Gyem Tshering, Wittaya Pimtong, Tullayakorn Plengsuriyakarn, Kesara Na-Bangchang
Effects of β-eudesmol and atractylodin on target genes and hormone related to cardiotoxicity, hepatotoxicity, and endocrine disruption in developing zebrafish embryos. Science progress 105 (4) (2022)
Pathanin Chantree, Kesara Na-Bangchang, Pongsakorn Martviset
Anticancer Activity of Fucoidan via Apoptosis and Cell Cycle Arrest on Cholangiocarcinoma Cell. Asian Pacific journal of cancer prevention : APJCP 22 (1) (2021)
Kanawut Kotawong, Wanna Chajaroenkul, Sittiruk Roytrakul, Narumon Phaonakrop, Kesara Na-Bangchang
The Proteomics and Metabolomics Analysis for Screening the Molecular Targets of Action of β-Eudesmol in Cholangiocarcinoma. Asian Pacific journal of cancer prevention : APJCP 22 (3) (2021)
Pongsakorn Martviset, Luxsana Panrit, Pathanin Chantree, Phunuch Muhamad, Kesara Na-Bangchang
Suppression of Cholangiocarcinoma Cell Growth and Proliferation by Atractylodes lancea (Thunb) DC. through ERK-Signaling Cascade. Asian Pacific journal of cancer prevention : APJCP 22 (11) (2021)
Phunuch Muhamad, Luxsana Panrit, Wanna Chaijaroenkul, Kesara Na-Bangchang
Cytotoxicity, Cell Cycle Arrest, and Apoptosis Induction Activity of Ethyl-p-methoxycinnamate in Cholangiocarcinoma Cell. Asian Pacific journal of cancer prevention : APJCP 21 (4) (2020)
Artitaya Thiengsusuk, Kanyarat Boonprasert, Kesara Na-Bangchang
A Systematic Review of Drug Metabolism Studies of Plants With Anticancer Properties: Approaches Applied and Limitations. European journal of drug metabolism and pharmacokinetics 45 (2) (2020)
Panida Kongjam, Lakshmanan Jeyaseelan, Wanna Chaijaroenkul, Kesara Na-Bangchang
Systematic Analysis of the Application and Inappropriate Use/Misuse of Statistics in Cholangiocarcinoma Research in Southeast Asia. Asian Pacific journal of cancer prevention : APJCP 21 (2) (2020)
Nadda Muhamad, Kesara Na-Bangchang
Metabolite Profiling in Anticancer Drug Development: A Systematic Review. Drug design, development and therapy 14 (2020)
Kanawut Kotawong, Wanna Chaijaroenkul, Sittiruk Roytrakul, Narumon Phaonakrop, Kesara Na-Bangchang
Proteomics Analysis for Identification of Potential Cell Signaling Pathways and Protein Targets of Actions of Atractylodin and β-Eudesmol Against Cholangiocarcinoma. Asian Pacific journal of cancer prevention : APJCP 21 (3) (2020)
Abdifetah Ibrahim Omar, Tullayakorn Plengsuriyakarn, Chuda Chittasupho, Kesara Na-Bangchang
Enhanced oral bioavailability and biodistribution of atractylodin encapsulated in PLGA nanoparticle in cholangiocarcinoma. Clinical and experimental pharmacology & physiology 48 (3) (2020)
Nada Muhamad, Tullayakorn Plengsuriyakarn, Chuda Chittasupho, Kesara Na-Bangchang
The Potential of Atractylodin-Loaded PLGA Nanoparticles as Chemotherapeutic for Cholangiocarcinoma. Asian Pacific journal of cancer prevention : APJCP 21 (4) (2020)
Sonam Wangchuk, Sonam Gyeltshen, Kunzang Dorji, Tenzin Wangdi, Tobgyel Dukpa, Rinzin Namgay, Sithar Dorjee, Tashi Tobgay, Wanna Chaijaroenkul, Kesara Na-Bangchang
Malaria elimination in Bhutan: asymptomatic malaria cases in the Bhutanese population living in malaria-risk areas and in migrant workers from India. Revista do Instituto de Medicina Tropical de Sao Paulo 61 (2019)
Juntra Karbwang, Francis P Crawley, Kesara Na-Bangchang, Cecilia Maramba-Lazarte
Herbal Medicine Development: Methodologies, Challenges, and Issues. Evidence-based complementary and alternative medicine : eCAM 2019 (2019)
Inthuorn Kulma, Kanyarat Boonprasert, Kesara Na-Bangchang
Polymorphisms of genes encoding drug transporters or cytochrome P450 enzymes and association with clinical response in cancer patients: a systematic review. Cancer chemotherapy and pharmacology 84 (5) (2019)
Artitaya Thiengsusuk, Phunuch Muhamad, Wanna Chaijaroenkul, Kesara Na-Bangchang
Antimalarial Activity of Piperine. Journal of tropical medicine 2018 (2018)
Vivek B Mathema, Wanna Chaijaroenkul, Kesara Na-Bangchang
Cytotoxic activity and molecular targets of atractylodin in cholangiocarcinoma cells. The Journal of pharmacy and pharmacology 71 (2) (2018)
Kesara Na-Bangchang, Tullayakorn Plengsuriyakarn, Juntra Karbwang
Research and Development of Atractylodes lancea (Thunb) DC. as a Promising Candidate for Cholangiocarcinoma Chemotherapeutics. Evidence-based complementary and alternative medicine : eCAM 2017 (2017)